Oyster Point Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -425%. Total operating expenses were $119,669,000.
Profit Margin
| 2017 | 0 | -6.60M | |
|---|---|---|---|
| 2018 | 0 | -16.50M | |
| 2019 | 0 | -45.71M | |
| 2020 | 0 | -70.52M | |
| 2021 | 24.53M | -104.39M | -425.42% |
OYST Income Statement (2017 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 24.53M | 0 | 0 | 0 | 0 |
Cost of revenue | 1.52M | 0 | 0 | 0 | 0 |
Gross profit | 23.01M | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 24.23M | 39.81M | 33.62M | 13.75M | 3.63M |
Selling and marketing | 54.62M | 0 | 0 | 0 | 0 |
Total operating expenses | 119.66M | 70.98M | 47.30M | 16.73M | 5.68M |
Operating income | -96.92M | -70.98M | -47.30M | -16.73M | -5.68M |
Other income (expenses), net | -3.73M | 469K | 1.59M | 233K | -918K |
Income before tax | -100.65M | -70.52M | -45.71M | -16.50M | -6.60M |
Income tax expense | 3.73M | 469K | 1.59M | 0 | 0 |
Net income | -104.39M | -70.52M | -45.71M | -16.50M | -6.60M |
Earnings per share | |||||
Basic EPS | -4.01 | -2.92 | -9.97 | -1.83 | -0.73 |
Diluted EPS | -4.01 | -2.92 | -9.97 | -1.83 | -0.73 |
| Data source | Data source | Data source |